Please assess the completion status of the following clinical trial:

Trial Title: Femoral Blockade and Low-dose Spinal Anesthesia in Outpatient Knee Arthroscopy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* ASA I-II patients aged between 25-65 undergoing arthroscopic meniscus repair~Exclusion Criteria:~* Contraindications to regional anesthesia (coagulopathy, severe aortic stenosis, sever mitral stenosis, increased intracranial pressure, severe hypovolemia, presence of infection on the site of injection)~* Presence of previous spinal surgery~* Presence of diabetes mellitus~* Presence of neurological disturbance~* Uncooperated patients, patients not accepting to participate the study~* Allergy to study drugs~* ASA II-IV patients, BMI \>38, Height \< 150 cm and \>190 cm

- Gender: ALL
- Minimum Age: 25 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Group F (Type: ACTIVE_COMPARATOR): Ultrasound-guided femoral blockade with 15 mL of bupivacaine 0.5% diluted in 15 mL saline was performed in supine position. Then the patient was turned to lateral decubitus position with the operated extremity on dependant position and intrathecal injection of heavy bupivacaine 1 mL (5 mg) was administered from L3-L4 intervertebral space at a rate of 1 mL/20 second.~.
- Group S (Type: ACTIVE_COMPARATOR): The patient was turned to lateral decubitus position with the operated extremity on dependant position and intrathecal injection of heavy bupivacaine 2 mL (10 mg) was administered from L3-L4 intervertebral space at a rate of 1 mL/20 second.

Based on this trial design, predict the completion outcome and termination type (if applicable).